corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 10744

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Kingsley & Kingsley Announces Pharmaceutical Reps File Overtime Lawsuits Against Bristol-Myers Squibb and Abbot Laboratories
Business Wire 2007 Jun 28
http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20070627006312&newsLang=en


Full text:

Virtually All Major Drug Companies Now Face Class Action Suits for Violating Federal and State Labor Laws

LOS ANGELES—(BUSINESS WIRE)—This morning, pharmaceutical representatives filed lawsuits against the pharmaceutical giants Bristol-Myers Squibb and Abbott Laboratories. The suits are the latest in a series of class actions by employees for violation of state and federal overtime laws by drug companies. All of the largest drug companies are now facing national overtime lawsuits filed in state and federal courts in California, New York, New Jersey, Illinois and Connecticut.

The lawsuits against Bristol-Myers are being filed in federal court in New York and in state court in California; the suit against Abbott is being filed in federal court in Chicago. The new lawsuits charge that the companies – like others in the industry – unlawfully characterize pharmaceutical representatives as “exempt” under the Fair Labor Standards Act and other labor laws, thus depriving the reps of overtime pay earned and owed.

Although pharmaceutical reps are often given fancy titles, they have little or no decision-making responsibility and their jobs should be covered by state and federal overtime laws, the lawsuits charge.

These and earlier cases filed in recent months – against AstraZeneca, Johnson & Johnson, Amgen, Eli Lilly, Hoffman LaRoche, Novartis, Merck, Wyeth, GlaxoSmithKline, Bayer, Boehringer-Ingelheim, Schering-Plough and Sanofi Aventis – are being litigated by the Los Angeles based-firms of Kingsley & Kingsley, LLP and Spiro Moss Barness LLP, the New York firm of Joseph and Herzfeld, LLP and/or the Washington, DC law firm of Sanford Wittels & Heisler, LLP. The New York firm of Emery Celli Brinckerhoff & Abady LLP is also litigating the Bristol-Myers Squibb and the Eli Lilly action, in which it is joined by the New York office of Seeger Weiss.

“The industry as a whole employs about 100,000 reps,” said Eric Kingsley of Kingsley & Kingsley. “They routinely work very long hours, often 60 hours a week and sometimes up to 70 or more.”

“Although the companies claim that the representatives are salespersons and therefore not protected by overtime laws, with some exceptions, they actually don’t sell anything,” explained Charles Joseph of Joseph & Herzfeld. “Rather, they are tasked to influence the prescribing behaviors of doctors. Many employees in all industries are under the mistaken impression that being salaried means that they are not protected under the overtime laws. But a salaried employee is entitled to overtime unless they fit within one of the closely defined exceptions to the rule.”

“These are loyal, hardworking employees who play by the rules,” said Ilann Maazel of Emery Celli Brinckerhoff & Abady LLP. “There is no excuse for Bristol-Myers’ failure to properly compensate its employees.”

Plaintiff Beth Amendola of Coconut Creek, Florida, who was at Bristol-Myers Squibb from 1998 until 2006, won top regional sales awards five of the eight years she worked at the company. “We would be in the field from 8 AM until 5 PM, and then have 3-4 hours of paperwork to complete at night. I was always at their beck and call. I felt like the Sorcerers’ Apprentice where all the pails and buckets kept coming, no matter how much work I did. Overtime was mandatory; overtime pay was not an option.”

Recent class action lawsuits have won multimillion-dollar settlements for insurance adjusters and computer technicians who were illegally denied overtime by employers who claimed they were exempt.

Class certification has been granted in the case against Novartis (Lopes v. Novartis), which was originally filed by Sanford Wittels in March 2006. “Hundreds of Novartis reps have joined the suit and we expect shortly that many more will,” said attorney David Sanford, who has also filed a sex discrimination lawsuit against the company.

The law firms have set up a website: www.pharmarepovertime.com and toll-free numbers: 888-500-8469 and 866-348-7394 for current and former pharmaceutical company employees who are interested in joining the lawsuits.

According to Kingsley, more than 500 pharmaceutical reps have already called the hotline. “Each time, the reps tell us how they have been forced to work nights and weekends on a regular basis and have not been paid overtime,” he noted.

Plaintiffs who call the hotline describe how their jobs have changed dramatically over the years. In the past, pharmaceutical representatives had the freedom to use their own educated judgment and creativity in marketing the drugs. In the last several years, however, perhaps because of lawsuits over drug marketing and increasing FDA scrutiny, companies have insisted that the representatives use memorized scripts or stick to regimented guidelines as to what they may and may not say. “The complete loss of autonomy in making decisions and scheduling work and family life is a great source of frustration,” said Kingsley. “Many reps feel that what was once a desirable job has turned into rote performance under intense scrutiny at the whim of their immediate supervisors. This is difficult for all reps, but is particularly hard on women with children.”

Bristol-Myers Squibb Company is a multibillion-dollar Delaware Corporation with headquarters in New York City; Abbott Laboratories is headquartered in Illinois; the company’s revenue last year was more than $22 billion. Both corporations do business throughout the United States and internationally.

The proposed classes in the combined lawsuits include tens of thousands of pharmaceutical representatives throughout the country. The plaintiffs are asking federal and state courts to order the drug companies to provide overtime pay going forward to eligible employees as well as compensation and damages to current and former employees who were unfairly denied overtime in the past.

Further Information

Members of the media can obtain copies of the complaints by going to the website: www.pharmarepovertime.com.

Current and former pharmaceutical company representatives who wish to learn more about the lawsuits or to join the lawsuits should visit www.pharmarepovertime.com or call (888) 500-8469 or (866) 348-7394 to contact plaintiffs’ attorneys.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend